William Volk, MD
Orthopaedic Surgery · Olney, MDNPI 1235384637
Payments from drug & device makers
Across 87 payments — averaging $186.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Supreme Orthopedic Systems, LLC$5K
- Arthrex$3K
- Arthrosurface Incorporated$2K
- Stryker$321
- Zimmer Biomet$144
- plus $293 from 9 others
What the payments were for
- Travel & lodging$5,72235%
- Food & beverage$4,07025%
- Education$6,40540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 30 | $5,350 |
| Supreme Orthopedic Systems, LLC | 16 | $5,015 |
| Arthrex | 17 | $3,478 |
| Arthrosurface Incorporated | 4 | $1,595 |
| Stryker | 7 | $321 |
| Zimmer Biomet | 1 | $144 |
| Johnson & Johnson | 2 | $57 |
| Medline Industries LP | 2 | $55 |
| Pacira Pharmaceuticals Incorporated | 2 | $49 |
| Acumed LLC | 1 | $29 |
| Anika Therapeutics, Inc. | 1 | $28 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Globus Medical | 1 | $20 |
| Eagle Pharmaceuticals, Inc. | 1 | $17 |
| Vericel Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Q-FIX Hip$2,915
- Hipstruments$2,915
- HemiCAP Shoulder$1,595
- Latarjet System$688
- Q-FIX$688
- ACCUPASS DIRECT Crescent XL$588
- Regeneten$365
- MULTIFIX S$219
- Hip Positioning System$175
- Wrist Fusion Pins$144
- Bioinductive Implant with Arthroscopic Delivery System - Medium$143
- OR3O Dual Mobility$130
- POLARSTEM$130
- RI.HIP NAVIGATION$130
- HIPMAP$124
- COBRA$124
- FLOWPORT CANNULA SYSTEM$124
- IVY AIR$124
- CROSSFLOW PUMP$124
How this compares
$16,196 in reported general payments places this provider in the 75th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 41 | $844 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 59 | $416 |
| Ondansetron OdtOndansetron | 35 | $312 |
| Meloxicam | 43 | $278 |
| Naproxen | 31 | $227 |
| Methylprednisolone | 23 | $152 |
| Tramadol Hcl | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Olney
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$8.1M
- Anand MurthiBaltimore$5.4M
- Timothy CoddTowson$3.7M
- Khaled KebaishBaltimore$3.5M
- Hamid HassanzadehBethesda$2M
- Michael AinLutherville$1.6M
- Paul SponsellerBaltimore$1.5M
- Shawn StandardBaltimore$1.4M
- Ronald DelanoisBaltimore$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.